Document:

exv10w2

EXHIBIT 10.2

THERMO FISHER SCIENTIFIC INC.

EXECUTIVE SEVERANCE POLICY

     1. Introduction. The Thermo Fisher Scientific Inc. Executive Severance Policy (the
“Policy”) is designed to provide separation pay and benefits to certain eligible Executives of
Thermo Fisher Scientific Inc. (the “Company”) whose employment is involuntarily terminated without
cause. This document constitutes the written instrument under which the Policy is maintained and
supersedes any prior plan or practice of the Company that provides severance benefits to
Executives, including without limitation, the relevant terms of any individual offer or employment
letter or contract. Notwithstanding the foregoing sentence, if an Executive is party to an
agreement with the Company providing for the payment of benefits in the event the employment of
such Executive is terminated after a Change in Control (a “Change in Control Agreement”), such
Change in Control Agreement shall not be terminated or cancelled by this Policy and such Change in
Control Agreement shall survive and remain in effect in accordance with its own terms. In the
event such Executive actually receives benefits under a Change in Control Agreement, such Executive
shall not also be entitled to receive benefits under this Policy. This Policy shall become
effective as of January 1, 2009.

     2. Key Definitions.

     As used herein, the following terms shall have the following respective meanings:

          2.1 “Change in Control” means an event or occurrence set forth in any one or more of
subsections (a) through (d) below (including an event or occurrence that constitutes a Change in
Control under one of such subsections but is specifically exempted from another such subsection):

               (a) the acquisition by an individual, entity or group (within the meaning of Section 13(d)(3)
or 14(d)(2) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) (a “Person”)
of beneficial ownership of any capital stock of the Company if, after such acquisition, such Person
beneficially owns (within the meaning of Rule 13d-3 promulgated under the Exchange Act) 50% or more
of either (i) the then-outstanding shares of common stock of the Company (the “Outstanding Company
Common Stock”) or (ii) the combined voting power of the then-outstanding securities of the Company
entitled to vote generally in the election of directors (the “Outstanding Company Voting
Securities”); provided, however, that for purposes of this subsection (a), the
following acquisitions shall not constitute a Change in Control: (i) any acquisition by the
Company, (ii) any acquisition by any employee benefit plan (or related trust) sponsored or
maintained by the Company or any corporation controlled by the Company, or (iii) any acquisition by
any corporation pursuant to a transaction which complies with clauses (i) and (ii) of subsection
(c) of this Section 1.1; or

               (b) such time as the Continuing Directors (as defined below) do not constitute a majority of
the Board (or, if applicable, the Board of Directors of a successor corporation to the Company),
where the term “Continuing Director” means at any date a member

 

of the Board (i) who was a member of the Board on the date of the execution of this Agreement or
(ii) who was nominated or elected subsequent to such date by at least a majority of the directors
who were Continuing Directors at the time of such nomination or election or whose election to the
Board was recommended or endorsed by at least a majority of the directors who were Continuing
Directors at the time of such nomination or election; provided, however, that there
shall be excluded from this clause (ii) any individual whose initial assumption of office occurred
as a result of an actual or threatened election contest with respect to the election or removal of
directors or other actual or threatened solicitation of proxies or consents, by or on behalf of a
person other than the Board; or

               (c) the consummation of a merger, consolidation, reorganization, recapitalization or statutory
share exchange involving the Company or a sale or other disposition of all or substantially all of
the assets of the Company in one or a series of transactions (a “Business Combination”), unless,
immediately following such Business Combination, each of the following two conditions is satisfied:
(i) all or substantially all of the individuals and entities who were the beneficial owners of the
Outstanding Company Common Stock and Outstanding Company Voting Securities immediately prior to
such Business Combination beneficially own, directly or indirectly, more than 50% of the
then-outstanding shares of common stock and the combined voting power of the then-outstanding
securities entitled to vote generally in the election of directors, respectively, of the resulting
or acquiring corporation in such Business Combination (which shall include, without limitation, a
corporation which as a result of such transaction owns the Company or substantially all of the
Company’s assets either directly or through one or more subsidiaries) (such resulting or acquiring
corporation is referred to herein as the “Acquiring Corporation”) in substantially the same
proportions as their ownership, immediately prior to such Business Combination, of the Outstanding
Company Common Stock and Outstanding Company Voting Securities, respectively; and (ii) no Person
(excluding the Acquiring Corporation or any employee benefit plan (or related trust) maintained or
sponsored by the Company or by the Acquiring Corporation) beneficially owns, directly or
indirectly, 50% or more of the then outstanding shares of common stock of the Acquiring
Corporation, or of the combined voting power of the then-outstanding securities of such corporation
entitled to vote generally in the election of directors; or

               (d) approval by the stockholders of the Company of a complete liquidation or dissolution of
the Company.

          2.2 “Cause” means the Executive’s willful engagement in illegal conduct or gross
misconduct which is materially and demonstrably injurious to the Company. For purposes of this
Section 2.2, no act or failure to act by the Executive shall be considered “willful” unless it is
done, or omitted to be done, in bad faith and without reasonable belief that the Executive’s action
or omission was in the best interests of the Company.

          2.3 “Continuation Period” means a period beginning on the date of termination of the
Executive and continuing for 18 consecutive months in the case of an Officer and for 12 consecutive
months in the case of an Executive who is not an Officer.

-2-

 

          2.4 “Disability” means the Executive’s inability, due to a physical or mental
disability, for a period of 90 days, whether or not consecutive, during any 360-day period to
perform the Executive’s duties on behalf of the Company, with or without reasonable accommodation
as that term is defined under state or federal law. A determination of disability shall be made by
a physician satisfactory to both the Executive and the Company, provided that if
the Executive and the Company do not agree on a physician, the Executive and the Company shall each
select a physician and these two together shall select a third physician, whose determination as to
disability shall be binding on all parties.

          2.5 “Executive” means an employee of the Company who has been classified by the Company as a
Career Band VII Employee or an officer; provided, however, that an employee who is party to an agreement with the
Company providing for the payment of separation benefits in the event the employment of such
Executive is terminated without cause (other than a Change in Control Agreement) shall not be
considered to be an Executive for purposes of this Policy.

          2.6 “Officer” means an Executive who has been designated by the Company’s Board of Directors
as an officer of the Company.

          2.7 “Severance Multiplier” means 1.5 for an Officer and 1.0 for an Executive who is not an
Officer.

     3. Not an Employment Contract. This Policy does not constitute a contract of
employment or impose on the Company any obligation to retain any Executive as an employee and does
not prevent any Executive from terminating employment at any time.

     4. Benefits to Executives.

          4.1 Compensation.

               (a) Termination Without Cause. If an Executive’s employment with the Company is
terminated by the Company (other than for Cause, Disability or death) then the Executive shall be
entitled to the following benefits:

                    (i) the Company shall pay to the Executive in a lump sum in cash within 30 days after the date
of termination the aggregate of the following amounts:

                         (A) the Executive’s Severance Multiplier times the Executive’s annual base salary as in effect
immediately prior to the date of termination, (B) the Executive’s Severance Multiplier times the
Executive’s target bonus for the year in which the date of termination occurs and (C) the amount of
any accrued vacation pay, to the extent not previously paid; and

                    (ii) for the Executive’s Continuation Period, or such longer period as may be provided by the
terms of the appropriate plan, program, practice or policy, the Company shall continue to provide
medical, dental and life insurance benefits to the Executive and the Executive’s family at least
equal to those which would have been provided to them if the

-3-

 

Executive’s employment had not been terminated, in accordance with the applicable benefit plans in
effect on the date of termination or, if more favorable to the Executive and the Executive’s
family, in effect generally at any time thereafter with respect to other peer executives of the
Company and its affiliated companies; provided, however, that (A) if the terms of a
benefit plan do not permit continued participation therein by a former employee, then an equitable
arrangement shall be made by the Company (such as a substitute or alternative plan) to provide as
substantially equivalent a benefit as is reasonably possible and (B) if the Executive becomes
reemployed with another employer and is eligible to receive a particular type of benefit (e.g.,
medical insurance benefits) from such employer on terms at least as favorable to the Executive and
the Executive’s family as those being provided by the Company, then the Company shall no longer be
required to provide those particular benefits to the Executive and the Executive’s family; and

                    (iii) to the extent not previously paid or provided, the Company shall timely pay or provide
to the Executive any other amounts or benefits required to be paid or provided or which the
Executive is eligible to receive following the Executive’s termination of employment under any
plan, program, policy, practice, contract or agreement of the Company and its affiliated companies
(other than severance benefits) (such other amounts and benefits described in this clause (iii)
shall be hereinafter referred to as the “Other Benefits”).

               (b) Termination for Cause, Disability or Death. If the Company terminates the
Executive’s employment with the Company because of the Executive’s disability, the Executive’s
death or for Cause, then the Company shall (i) pay the Executive or the Executive’s estate, in a
lump sum in cash within 30 days after the date of termination, the Executive’s base salary through
the date of termination and (ii) timely pay or provide to the Executive the Other Benefits.

          4.2 Outplacement Services. In the event the Executive is terminated by the Company
(other than for Cause, Disability or death), the Company shall provide outplacement services
through one or more outside firms of the Executive’s choosing up to an aggregate of $20,000, with
such services to extend until the earlier of (i) 12 months following the termination of the
Executive’s employment or (ii) the date the Executive secures full time employment.

          4.3 Mitigation. The Executive shall not be required to mitigate the amount of any
payment or benefits provided for in this Section 4 by seeking other employment or otherwise.
Further, except as provided in Section 4.1(a)(ii), the amount of any payment or benefits provided
for in this Section 4 shall not be reduced by any compensation earned by the Executive as a result
of employment by another employer, by retirement benefits, by offset against any amount claimed to
be owed by the Executive to the Company or otherwise.

          4.4. Release of Claims by Executive. The Executive shall not be entitled to any
payments or other benefits hereunder unless the Executive executes and, if applicable, does not
revoke, a full and complete release of claims and separation agreement, in the form to be provided
by the Company.

-4-

 

          4.5 Non-Compete Obligations. An Officer shall not be entitled to any payments or
other benefits hereunder unless the Officer has, prior to the effective date of this Policy,
executed a Non-Compete Agreement with the Company providing for a restriction period of 18 months.

     5. Disputes. All claims by the Executive for benefits under this Agreement shall be
directed to and determined by the Board and shall be in writing. Any denial by the Board of a
claim for benefits under this Agreement shall be delivered to the Executive in writing and shall
set forth the specific reasons for the denial. The Board shall afford a reasonable opportunity to
the Executive for a review of the decision denying a claim. Any further dispute or controversy
arising under or in connection with this Agreement shall be settled exclusively by arbitration in
Boston, Massachusetts, in accordance with the rules of the American Arbitration Association then in
effect. Judgment may be entered on the arbitrator’s award in any court having jurisdiction.

     6. Successors.

          6.1 Successor to Company. The Company shall require any successor (whether direct or
indirect, by purchase, merger, consolidation or otherwise) to all or substantially all of the
business or assets of the Company expressly to assume and agree to perform this Policy to the same
extent that the Company would be required to perform it if no such succession had taken place. As
used in this Agreement, “Company” shall mean the Company as defined above and any successor to its
business or assets as aforesaid which assumes and agrees to perform this Agreement, by operation of
law or otherwise.

          6.2 Successor to Executive. This Agreement shall inure to the benefit of and be
enforceable by the Executive’s personal or legal representatives, executors, administrators,
successors, heirs, distributees, devisees and legatees. If the Executive should die while any
amount would still be payable to the Executive or the Executive’s family hereunder if the Executive
had continued to live, all such amounts, unless otherwise provided herein, shall be paid in
accordance with the terms of this Agreement to the executors, personal representatives or
administrators of the Executive’s estate.

     7. Notice. All notices, instructions and other communications given hereunder or in
connection herewith shall be in writing. Any such notice, instruction or communication shall be
sent either (i) by registered or certified mail, return receipt requested, postage prepaid, or (ii)
prepaid via a reputable nationwide overnight courier service, in each case addressed to the
Company, at 81 Wyman Street, Waltham, Massachusetts and to the Executive at the Executive’s
principal residence as currently reflected on the Company’s records (or to such other address as
either the Company or the Executive may have furnished to the other in writing in accordance
herewith). Any such notice, instruction or communication shall be deemed to have been delivered
five business days after it is sent by registered or certified mail, return receipt requested,
postage prepaid, or one business day after it is sent via a reputable nationwide overnight courier
service. Either party may give any notice, instruction or other communication hereunder using any
other means, but no such notice, instruction or other communication shall be

-5-

 

deemed to have been duly delivered unless and until it actually is received by the party for
whom it is intended.

     8. Miscellaneous.

          8.1 Severability. The invalidity or unenforceability of any provision of this Policy
shall not affect the validity or enforceability of any other provision of this Policy, which shall
remain in full force and effect.

          8.2 Governing Law. The validity, interpretation, construction and performance of this
Policy shall be governed by the internal laws of the Commonwealth of Massachusetts, without regard
to conflicts of law principles.

          8.3 Waivers. No waiver by the Executive at any time of any breach of, or compliance
with, any provision of this Policy to be performed by the Company shall be deemed a waiver of that
or any other provision at any subsequent time.

          8.4 Tax Withholding. Any payments provided for hereunder shall be paid net of any
applicable tax withholding required under federal, state or local law.

          8.5 Amendments. This Policy may be amended or terminated by the Company at any time;
provided that this Section 8.5 shall have no force or effect after the occurrence of a Change of
Control.

     9. Section 409A Compliance.

     The following rules shall apply with respect to distribution of the payments and benefits, if
any, to be provided to the Executive under this Policy:

          9.1 It is intended that each installment of the payments and benefits provided under Section 4
shall be treated as a separate “payment” for purposes of Section 409A of the Internal Revenue Code
of 1986 and the guidance issued thereunder (“Section 409A”). Neither the Company nor the Executive
shall have the right to accelerate or defer the delivery of any such payments or benefits except to
the extent specifically permitted or required by Section 409A.

          9.2 If, as of the date of the “separation from service” of the Executive from the Company
(determined as set forth below), the Executive is not a “specified employee” (within the meaning of
Section 409A), then each installment of the payments and benefits shall be made on the dates and
terms set forth in Section 4.

          9.3 If, as of the date of the “separation from service” of the Executive from the Company, the
Executive is a “specified employee” (within the meaning of Section 409A), then:

-6-

 

               (a) Each installment of the payments and benefits due under Section 4, that, in accordance
with the dates and terms set forth herein, will in all circumstances, regardless of when the
separation from service occurs, be paid within the Short-Term Deferral Period (as hereinafter
defined) shall be treated as a short-term deferral within the meaning of Treasury Regulation §
1.409A-1(b)(4) to the maximum extent permissible under Section 409A. For purposes of this Policy,
the “Short-Term Deferral Period” means the period ending on the later of the 15th day of
the third month following the end of the Executive’s tax year in which the separation from service
occurs and the 15th day of the third month following the end of the Company’s tax year
in which the separation from service occurs; and

               (b) Each installment of the payments and benefits due under Section 4 that is not described
in clause (a), above, and that would, absent this subsection, be paid within the six-month period
following the “separation from service” of the Executive from the Company shall not be paid until
the date that is six months and one day after such separation from service (or, if earlier, the
Executive’s death), with any such installments that are required to be delayed being accumulated
during the six-month period and paid in a lump sum on the date that is six months and one day
following the Executive’s separation from service and any subsequent installments, if any, being
paid in accordance with the dates and terms set forth herein; provided, however,
that the preceding provisions of this sentence shall not apply to any installment of payments and
benefits if and to the maximum extent that that such installment is deemed to be paid under a
separation pay plan that does not provide for a deferral of compensation by reason of the
application of Treasury Regulation § 1.409A-1(b)(9)(iii) (relating to separation pay upon an
involuntary separation from service). Any installments that qualify for the exception under
Treasury Regulation § 1.409A-1(b)(9)(iii) must be paid no later than the last day of the
Executive’s second taxable year following his taxable year in which the separation from service
occurs.

          9.4 The determination of whether and when a separation from service of the Executive from the
Company has occurred shall be made in a manner consistent with, and based on the presumptions set
forth in, Treasury Regulation § 1.409A-1(h). Solely for purposes of this Section 9.4, “Company”
shall include all persons with whom the Company would be considered a single employer under Section
414(b) and 414(c) of the Code.

          9.5 All reimbursements and in-kind benefits provided under the Policy shall be made or
provided in accordance with the requirements of Section 409A to the extent that such reimbursements
or in-kind benefits are subject to Section 409A.

-7-exv10w3

EXHIBIT 10.3

THERMO FISHER SCIENTIFIC INC.

NONSTATUTORY STOCK OPTION AGREEMENT

Granted Under

2005 Stock Incentive Plan, 

as amended and restated on November 9, 2006

1. Grant of Option.

     This agreement evidences the grant by Thermo Fisher Scientific Inc., a Delaware corporation
(the “Company”), on May 15, 2008 (the “Grant Date”) to Marc N. Casper (the “Participant”), an
employee and officer of the Company, of an Option to purchase, in whole or in part, on the terms
provided herein and in the Company’s 2005 Stock Incentive Plan, as amended and restated on November
9, 2006, (the “Plan”), a total of 375,000 shares (the “Shares”) of common stock, $1.00 par value
per share, of the Company (“Common Stock”) at $57.58 per Share. Unless earlier terminated, this
Option shall expire at 5:00 p.m., Eastern time, on May 15, 2015 (the “Final Exercise Date”).

     It is intended that the Option evidenced by this agreement shall not be an incentive stock
Option as defined in Section 422 of the Code. Except as otherwise indicated by the context, the
term “Participant”, as used in this Option, shall be deemed to include any person who acquires the
right to exercise this Option validly under its terms. Capitalized terms used in this Agreement
and not otherwise defined shall have the same meaning as in the Plan.

2. Vesting Schedule. Except as otherwise provided in paragraphs (d) through (h) of Section
3 below and the Plan, this Option will become exercisable (“vest”) as to 20% of the original number
of Shares on the first anniversary of the Grant Date and as to an additional 20% of the original
number of Shares at the end of each anniversary of the Grant Date following the first anniversary
of the Grant Date until the fifth anniversary of the Grant Date. The right of exercise shall be
cumulative so that to the extent the Option is not exercised in any period to the maximum extent
permissible it shall continue to be exercisable, in whole or in part, with respect to all Shares
for which it is vested until the earlier of the Final Exercise Date or the termination of this
Option under Section 3 hereof.

3. Exercise of Option.

     (a) Form of Exercise. Each election to exercise this Option shall be in accordance
with the instructions described in “The Guide for Employees of Thermo Fisher Scientific Inc. Stock
Option Plans” as may be amended from time to time. The Participant may purchase less than the
number of shares covered hereby, provided that no partial exercise of this Option may be for any
fractional share.

     (b) Continuous Relationship with the Company Required. Except as otherwise provided
in this Section 3, this Option may not be exercised unless the Participant, at the time he

 

 

or she
exercises this Option, is, and has been at all times since the Grant Date, an employee, officer or
director of, or consultant or advisor to, the Company or any other entity the employees, officers,
directors, consultants, or advisors of which are eligible to receive Option grants under the Plan
(an “Eligible Participant”).

     (c) Termination of Relationship with the Company. If the Participant ceases to be an
Eligible Participant for any reason, then, except as provided in paragraphs (d)-(h) below, the
right to exercise this Option shall terminate three months after such cessation (but in no event
after the Final Exercise Date), provided that this Option shall be exercisable only
to the extent that the Participant was entitled to exercise this Option on the date of such
cessation.

     (d) Death or Disability. If the Participant dies or becomes disabled (as defined
below) prior to the Final Exercise Date while he or she is an Eligible Participant, this Option
shall vest and become 100% exercisable upon the date of such death or disability and the right to
exercise this Option shall terminate one year following such date (but in no event after the Final
Exercise Date). For the purposes of this Agreement, a Participant shall be deemed to be “disabled”
at such time as the Participant is receiving disability benefits under the Company’s Long Term
Disability Coverage, as then in effect.

     (e) Discharge Without Cause. If the Participant’s employment or service is terminated
by the Company or any Subsidiary without “Cause” (as defined in the Plan) prior to the Final
Exercise Date, this Option shall vest and become 100% exercisable upon the date of such termination
of employment or service and the right to exercise this Option shall terminate three months
following such date (but in no event after the Final Exercise Date).

     (f) Discharge for Cause. If the Participant, prior to the Final Exercise Date, is
discharged by the Company or a Subsidiary for “Cause” (as defined in the Plan), the right to
exercise this Option shall terminate immediately upon the effective date of such discharge. The
Participant shall be considered to have been discharged for Cause if the Company determines, within
30 days after the Participant’s resignation, that discharge for Cause was warranted.

     (g) Retirement. If the Participant “retires” from the Company or a Subsidiary prior
to the Final Exercise Date then, subject to Section 3(e) above, this Option shall vest and become
100% exercisable upon the date of such retirement and the right to exercise this Option shall
terminate eighteen months following such date (but in no event after the Final Exercise Date),
provided that the retirement date occurs at least one year after the Grant Date. For the
purposes of this Agreement, a Participant shall be deemed to have “retired” (i) in the event of a
non-employee director of the Company, when he or she ceases to be a director of the Company and
(ii) in the event of an employee of the Company or a Subsidiary, upon his or her resignation from
employment with the Company or a Subsidiary either (A) after the age of 55 and the completion of 10
continuous years service to the Company or a Subsidiary comprising at least 20 hours per week or
(B) after the age of 60 and the completion of 5 continuous years service to the Company or a
Subsidiary comprising at least 20 hours per week.

     (h) Change in Control Event. If the Participant’s employment or service is
terminated by the Company or any Subsidiary without “Cause” (as defined in the Plan) or by the
Participant for “Good Reason” (as defined in the Plan), in each case within 18 months following

-2-

 

a Change in Control Event, this Option shall vest and become 100% exercisable upon the date of such
termination of employment or service and the right to exercise this Option shall terminate one year
following such date (but in no event after the Final Exercise Date).

4. Withholding. No Shares will be issued pursuant to the exercise of this Option unless
and until the Participant pays to the Company, or makes provision satisfactory to the Company for
payment of, any federal, state or local withholding taxes required by law to be withheld in respect
of this Option in accordance with the instructions therefore described in “The Guide for Employees
of Thermo Fisher Scientific Inc. Stock Option Plans” as may be amended from time to time;
provided, however, except as otherwise permitted by the Board, the total tax
withholding where stock is being used to satisfy such tax obligations cannot exceed the Company’s
minimum statutory withholding obligations (based on minimum statutory withholding rates for federal
and state tax purposes, including payroll taxes, that are applicable to such supplemental taxable
income).

5. Nontransferability of Option. This Option may not be sold, assigned, transferred,
pledged or otherwise encumbered by the Participant, either voluntarily or by operation of law,
except by will or the laws of descent and distribution, and, during the lifetime of the
Participant, this Option shall be exercisable only by the Participant. Notwithstanding the
foregoing, the Company consents to the gratuitous transfer of this Option by the Participant to or
for the benefit of any immediate family member, family trust or family partnership established
solely for the benefit of the Participant and/or an immediate family member thereof;
provided that with respect to such proposed transferee the Company would be eligible to use
a Form S-8 for the registration of the sale of the Common Stock subject to such Option under the
Securities Act of 1933, as amended; and provided further that the Company shall not
be required to recognize any such transfer until such time as the Participant and such permitted
transferee shall, as a condition to such transfer, deliver to the Company a written instrument in
form and substance satisfactory to the Company confirming that such transferee shall be bound by
all of the terms and conditions of this Agreement.

6. Provisions of the Plan. This Option is subject to the provisions of the Plan, a copy of
which is furnished to the Participant with this Option.

7. No Right To Employment or Other Status. The grant of this Option shall not be
construed as giving the Participant the right to continued employment or any other relationship
with the Company or Subsidiary. The Company and Subsidiaries expressly reserve the right at any
time to dismiss or otherwise terminate its relationship with the Participant free from any
liability or claim under the Plan or this Agreement, except as expressly provided herein.

8. Restrictive Covenants. If the Participant engages in any conduct in breach of any
noncompetition, nonsolicitation or confidentiality obligations to the Company or any Subsidiary
under any agreement, policy or plan of the Company or any Subsidiary, then such conduct shall also
be deemed to be a breach of the terms of the Plan and this Agreement. Upon such breach, this
Option shall be cancelled and, to the extent some or all of this Option was exercised within a
period of 12 months prior to such breach, the Participant shall be required to forfeit to the
Company, upon demand, any cash or Shares acquired by the Participant upon such exercise or sale.

-3-

 

9. Governing Law. This Option shall be governed by and interpreted in accordance with the
laws of the State of Delaware, without regard to any applicable conflicts of law.

     IN WITNESS WHEREOF, the Company has caused this Option to be executed under its corporate seal by
its duly authorized officer. This Option shall take effect as a sealed instrument.

	 	 	 	 	 
	 	THERMO FISHER SCIENTIFIC INC.

 	 
	Dated: May 15, 2008 	By:  	 /s/
Steve Sheehan	 
	 	 	Name:  	Steve Sheehan 	 
	 	 	Title:  	Senior Vice President, Human Resources 	 
	 

-4-

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00142-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00142-of-00352.parquet"}]]